Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
TPTX | Turning Point Therapeutics, Inc. | Countouriotis Athena | President & CEO | Aug 17, 2022 | Option Exercise | $76.00 | 110,959 | 8,432,884 | 0 | Aug 17, 2022, 04:23 PM | |
TPTX | Turning Point Therapeutics, Inc. | Countouriotis Athena | President & CEO | Feb 09, 2022 | Sale | $36.30 | 2,971 | 107,847 | 47,930 | Feb 11, 2022, 06:07 PM | |
TPTX | Turning Point Therapeutics, Inc. | Countouriotis Athena | President & CEO | Feb 09, 2021 | Sale | $70.94 | 51,332 | 3,641,607 | 75,861 | Feb 11, 2021, 08:28 PM | |
TPTX | Turning Point Therapeutics, Inc. | Countouriotis Athena | President & CEO | Feb 10, 2021 | Sale | $69.75 | 50,784 | 3,542,371 | 75,587 | Feb 11, 2021, 08:28 PM | |
TPTX | Turning Point Therapeutics, Inc. | Countouriotis Athena | President & CEO | Feb 11, 2021 | Option Exercise | $70.29 | 17,884 | 1,257,060 | 59,137 | Feb 11, 2021, 08:28 PM | |
TPTX | Turning Point Therapeutics, Inc. | Countouriotis Athena | President & CEO | May 21, 2020 | Buy | $60.00 | 4,166 | 249,960 | 26,872 | May 26, 2020, 05:55 PM | |
PASG | Passage BIO, Inc. | Countouriotis Athena | Director | Mar 24, 2020 | Buy | $14.98 | 10,000 | 149,750 | 18,900 | Mar 25, 2020, 08:26 PM | |
PASG | Passage BIO, Inc. | Countouriotis Athena | Director | Mar 03, 2020 | Buy | $18.00 | 8,900 | 160,200 | 8,900 | Mar 03, 2020, 06:37 PM | |
TPTX | Turning Point Therapeutics, Inc. | Countouriotis Athena | President & CEO | Dec 10, 2019 | Option Exercise | $31.13 | 706 | 21,976 | 22,706 | Jan 08, 2020, 04:24 PM | |
TPTX | Turning Point Therapeutics, Inc. | Countouriotis Athena | President & CEO | Sep 10, 2019 | Buy | $45.00 | 10,000 | 450,000 | 22,000 | Sep 11, 2019, 04:15 PM | |
TPTX | Turning Point Therapeutics, Inc. | Countouriotis Athena | President & CEO | Apr 22, 2019 | Buy | $18.00 | 12,000 | 216,000 | 12,000 | Apr 24, 2019, 05:55 PM | |
HALO | HALOZYME THERAPEUTICS INC | Countouriotis Athena | SVP and Chief Medical Officer | Feb 03, 2017 | Option Exercise | $12.26 | 6,900 | 84,594 | 39,077 | Feb 06, 2017, 07:01 PM | |
HALO | HALOZYME THERAPEUTICS INC | Countouriotis Athena | SVP and Chief Medical Officer | Jun 30, 2016 | Option Exercise | $8.63 | 107 | 923 | 19,981 | Jul 05, 2016, 04:55 PM | |
HALO | HALOZYME THERAPEUTICS INC | Countouriotis Athena | SVP and Chief Medical Officer | Jan 05, 2016 | Option Exercise | $16.39 | 3,257 | 53,382 | 13,638 | Jan 07, 2016, 05:25 PM | |
HALO | HALOZYME THERAPEUTICS INC | Countouriotis Athena | SVP and Chief Medical Officer | Dec 31, 2015 | Option Exercise | $17.33 | 5,655 | 98,001 | 9,395 | Jan 04, 2016, 08:10 PM |